IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Novo Holdings A/S

Q4 2014 Holdings

Filed 2015-02-17 | 15 holdings | $18.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Akebia Therapeutics Inc(AKBA)COM00972D105$17.7M1,516,38793.5%
Vanguard Index FDS(VTI)TOTAL STK MKT922908769$315.8K2,979,1001.7%
Ophthotech CorpCOM683745103$264.8K5,901,8191.4%
Inogen Inc(INGN)COM45780L104$111.3K3,549,3200.6%
Vanguard Intl Equity Index F(VGK)FTSE EUROPE ETF922042874$110.1K2,101,0000.6%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$93.1K3,201,1830.5%
Nevro Corp(NVROEUR)COM64157F103$84.9K2,194,8410.4%
Otonomy IncCOM68906L105$72.5K2,175,0250.4%
Tetraphase Pharmaceuticals IncCOM88165N105$58.6K1,475,0000.3%
Flexion Therapeutics IncCOM33938J106$46.1K2,283,1310.2%
Wright Medical GroupContingent Value Rights98235T115$22.6K$4,720,0650.1%
Tokai Pharmaceuticals IncCOM88907J107$17.4K1,178,9920.1%
Aerie Pharmaceuticals Inc(AERIEUR)COM00771V108$12.3K419,6520.1%
Intersect ENT IncCOM46071F103$6.5K350,0000.0%
Xenon Pharmaceuticals Inc(XENE)COM98420N105$2.5K127,5630.0%